BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a specialty pharmaceutical company developing therapeutics for rare gastrointestinal and endocrine disorders, today announced the appointment of Colin Broom, M.D., to its board of directors. Dr. Broom is vice president and chief scientific officer of ViroPharma Incorporated. His appointment brings the number of NPS board members to seven.
